PROM1 and colonic neoplasm: Further, we observed using colon cancer stem cells marker CD133 [32] and CD44v6, a marker of constitutive and reprogrammed CSCs driving colon cancer metastasis [36] that the xenograft-derived cells have a lower stem cell content and activity.